BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 960064)

  • 1. Defibrinogenation as an alternative to heparinization during prolonged extracorporeal circulation in the dog.
    Berglin E; Hansson HA; Teger-Nilsson AC; William-Olsson G
    Thromb Res; 1976 Jul; 9(1):81-93. PubMed ID: 960064
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulation with defibrase during prolonged extracorporeal circulation in the dog.
    Berglin E; Svalander ; Teger-Nilsson A-C ; William-Olsson G
    Scand J Thorac Cardiovasc Surg; 1976; 10(3):225-30. PubMed ID: 1006222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defibrinogenation as an alternative to heparinization in prolonged extracorporeal circulation.
    Roy J; Guidoin R; Martin L; Lephat H; Blais P; Marois M; Gagnon D; Awad J
    Res Exp Med (Berl); 1980; 176(3):219-34. PubMed ID: 6988926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of anticoagulation methods available for extracorporeal circulation in the dog].
    Legendre L; Guidoin R; Martin L; Blais P; Marois M; Roy J; Awad J
    Union Med Can; 1980 Mar; 109(3):387-96. PubMed ID: 6990575
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Anticoagulation during six hours of extracorporeal perfusion. Comparison between heparinization and defibrinogenation.
    Berglin E; Hansson HA; Teger-Nilsson AC; Williams-Olsson G
    Thromb Diath Haemorrh; 1975 Nov; 34(2):578. PubMed ID: 1198477
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma administration to defibrinogenated dogs during extracorporeal circulation.
    Berglin E; Hansson HA; William-Olsson G
    Artif Organs; 1979 Feb; 3(1):80-5. PubMed ID: 435130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemostatic clot formation at anastomosis of synthetic venous graft in defibrinogenated dogs: a scanning electron microscopic study.
    Ishimaru S; Berglin E; Hansson HA; Teger-Nilsson AC; William-Olsson G
    Thromb Haemost; 1981 Jun; 45(3):276-81. PubMed ID: 7025342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACTIVATION OF COAGULATION AND FIBRINOGEN LOSS AFTER USING AN EXTRACORPOREAL CIRCULATION.
    BLOOM AL
    J Clin Pathol; 1963 Nov; 16(6):558-68. PubMed ID: 14076375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of GBH-coated Tygon tubing for experimental prolonged perfusions without systemic heparinization.
    Indeglia RA; Dorman FD; Castaneda AR; Varco RL; Bernstein EF
    Trans Am Soc Artif Intern Organs; 1966; 12():166-73. PubMed ID: 5960696
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolonged extracorporeal respiration with a membrane gas exchanger.
    Awad JA; Matte J; Brassard A
    J Thorac Cardiovasc Surg; 1973 Jul; 66(1):40-51. PubMed ID: 4715384
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of snake venom enzymes on blood coagulation.
    Kornalík F
    Pharmacol Ther; 1985; 29(3):353-405. PubMed ID: 3915360
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of calcium-induced reptilase clot retraction.
    Kubisz P; Suranová J; Cronberg S
    Scand J Haematol; 1976 Apr; 16(4):263-5. PubMed ID: 935809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in coagulation and platelet function during prolonged extracorporeal circulation (ECC) in sheep and man.
    Fong SW; Burns NE; Williams G; Woldanski C; Gazzaniga AB; Bartlett RH
    Trans Am Soc Artif Intern Organs; 1974; 20A():239-47. PubMed ID: 4450343
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reptilase and thrombin-coagulase times in full-term newborns and in the 1st years of life].
    Schettini F; De Mattia D; Mautone A; Altomare M
    Boll Soc Ital Biol Sper; 1975 Oct; 51(19):1229-33. PubMed ID: 1220740
    [No Abstract]   [Full Text] [Related]  

  • 15. Arvin anticoagulation for prolonged extracorporeal membrane oxygenation.
    Büky B; Bell W; Matthews P; Reidy T; White JJ
    Trans Am Soc Artif Intern Organs; 1973; 19():56-60. PubMed ID: 4722775
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of defibrinogenation with batroxobin on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Furukawa Y; Takemura S; Kato H; Kondo M
    Thromb Res; 1983 Sep; 31(5):729-35. PubMed ID: 6359574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bypass surgery on coagulation-sensitive clotting factors.
    Woods JE; Kirklin JW; Owen CA; Thompson JH; Taswell HF
    Mayo Clin Proc; 1967 Nov; 42(11):724-35. PubMed ID: 6053800
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet-surface interaction: effect of albumin coating or heparin complexing on thrombogenic surfaces.
    Chang TM
    Can J Physiol Pharmacol; 1974 Apr; 52(2):275-85. PubMed ID: 4838187
    [No Abstract]   [Full Text] [Related]  

  • 19. Modification of batroxobin with activated polyethylene glycol: reduction of binding ability towards anti-batroxobin antibody and retention of defibrinogenation activity in circulation of preimmunized dogs.
    Nishimura H; Takahashi K; Sakurai K; Fujinuma K; Imamura Y; Ooba M; Inada Y
    Life Sci; 1983 Oct; 33(15):1467-73. PubMed ID: 6353117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of snake venom, Defibrase, on haemostasis (author's transl)].
    Donner L; Klener P; Setková O
    Sb Lek; 1980; 82(7):203-11. PubMed ID: 6996078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.